Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Marvel Biosciences Corp. per 2025 Apr 30 adalah -1.33 MM.
- Nilai net income untuk Marvel Biosciences Corp. per 2025 Apr 30 adalah -1.61 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-04-30 | -1.33 | -1.61 | |
2025-01-31 | -1.31 | -1.66 | |
2024-10-31 | -1.01 | -1.41 | |
2024-07-31 | -1.22 | -1.65 | |
2024-04-30 | -1.93 | -2.10 | |
2024-01-31 | -2.37 | -2.51 | |
2023-10-31 | -2.35 | -2.51 | |
2023-07-31 | -2.19 | -2.29 | |
2023-04-30 | -1.73 | -1.83 | |
2023-01-31 | -1.44 | -1.50 | |
2022-10-31 | -2.28 | -2.34 | |
2022-07-31 | -2.51 | -2.55 | |
2022-04-30 | -2.37 | -4.06 | |
2022-01-31 | -2.27 | -4.09 | |
2021-10-31 | -1.39 | -3.19 | |
2021-07-31 | -1.25 | -3.04 | |
2021-04-30 | -1.12 | -1.20 | |
2021-01-31 | -1.43 | -1.36 | |
2020-10-31 | -1.38 | -1.31 | |
2020-07-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-04-30 | ||
2025-01-31 | ||
2024-10-31 | -0.03 | -0.03 |
2024-07-31 | -0.04 | |
2024-04-30 | ||
2024-01-31 | -0.06 | -0.06 |
2023-10-31 | -0.06 | -0.06 |
2023-07-31 | -0.06 | |
2023-04-30 | -0.05 | -0.05 |
2023-01-31 | -0.04 | -0.04 |
2022-10-31 | -0.07 | -0.07 |
2022-07-31 | -0.08 | |
2022-04-30 | -0.12 | -0.12 |
2022-01-31 | -0.15 | -0.15 |
2021-10-31 | -0.14 | -0.14 |
2021-07-31 | -0.17 | |
2021-04-30 | -0.10 | -0.10 |
2021-01-31 | -0.12 | -0.12 |
2020-10-31 | -0.13 | -0.13 |
2020-07-31 | -0.13 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Marvel Biosciences Corp. per 2025 Apr 30 adalah -1.16 MM.
- Nilai kas dari aktivitas pendanaan untuk Marvel Biosciences Corp. per 2025 Apr 30 adalah 1.33 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-04-30 | -1.16 | 1.33 | |
2025-01-31 | -0.99 | 0.47 | |
2024-10-31 | -1.20 | 0.97 | |
2024-07-31 | -1.18 | 0.97 | |
2024-04-30 | -1.28 | 0.50 | |
2024-01-31 | -1.22 | 1.50 | |
2023-10-31 | -1.22 | 1.00 | |
2023-07-31 | -1.33 | 1.30 | |
2023-04-30 | -1.33 | 1.69 | |
2023-01-31 | -1.25 | 0.69 | |
2022-10-31 | -2.27 | 0.69 | |
2022-07-31 | -2.19 | 0.39 | |
2022-04-30 | -2.31 | 0.38 | 2.45 |
2022-01-31 | -2.39 | 0.38 | 2.52 |
2021-10-31 | -1.30 | 0.38 | 2.73 |
2021-07-31 | -1.37 | 0.38 | 3.16 |
2021-04-30 | -1.05 | 0.91 | |
2021-01-31 | -0.99 | 1.08 | |
2020-10-31 | -0.85 | 1.16 | |
2020-07-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-04-30 | |||
2025-01-31 | |||
2024-10-31 | |||
2024-07-31 | |||
2024-04-30 | |||
2024-01-31 | |||
2023-10-31 | |||
2023-07-31 | |||
2023-04-30 | |||
2023-01-31 | |||
2022-10-31 | |||
2022-07-31 | |||
2022-04-30 | |||
2022-01-31 | |||
2021-10-31 | |||
2021-07-31 | |||
2021-04-30 | |||
2021-01-31 | |||
2020-10-31 | |||
2020-07-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-04-30 | ||
2025-01-31 | ||
2024-10-31 | 0.00 | -0.48 |
2024-07-31 | ||
2024-04-30 | ||
2024-01-31 | ||
2023-10-31 | ||
2023-07-31 | ||
2023-04-30 | ||
2023-01-31 | ||
2022-10-31 | ||
2022-07-31 | ||
2022-04-30 | ||
2022-01-31 | ||
2021-10-31 | ||
2021-07-31 | ||
2021-04-30 | ||
2021-01-31 | ||
2020-10-31 | ||
2020-07-31 |
Efektivitas Manajemen
- roa untuk Marvel Biosciences Corp. pada 2025 Apr 30 adalah -2.34.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-04-30 | -2.34 | ||||
2025-01-31 | -1.98 | ||||
2024-10-31 | 0.00 | ||||
2024-07-31 | -3.74 | ||||
2024-04-30 | |||||
2024-01-31 | -168.57 | ||||
2023-10-31 | -11.03 | ||||
2023-07-31 | -11.72 | ||||
2023-04-30 | -1.63 | -1.94 | |||
2023-01-31 | -1.63 | -1.94 | |||
2022-10-31 | -1.09 | -1.27 | -10.27 | -6.95 | -9.98 |
2022-07-31 | -19.45 | -10.59 | 1.35 | -6.04 | |
2022-04-30 | -9.31 | -18.38 | -5.27 | 0.67 | -3.08 |
2022-01-31 | -9.31 | -18.38 | -5.27 | 0.67 | -3.08 |
2021-10-31 | -10.27 | -25.58 | -1.28 | 0.91 | -0.58 |
2021-07-31 | |||||
2021-04-30 | |||||
2021-01-31 | -1,424.38 | -6.55 | 1.55 | -4.25 | |
2020-10-31 | -1,037.63 | -6.72 | 1.58 | -3.79 | |
2020-07-31 | -1,037.63 | -6.72 | 1.58 | -3.79 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-04-30 | |||
2025-01-31 | |||
2024-10-31 | |||
2024-07-31 | |||
2024-04-30 | |||
2024-01-31 | |||
2023-10-31 | |||
2023-07-31 | |||
2023-04-30 | |||
2023-01-31 | |||
2022-10-31 | |||
2022-07-31 | |||
2022-04-30 | |||
2022-01-31 | |||
2021-10-31 | |||
2021-07-31 | |||
2021-04-30 | |||
2021-01-31 | |||
2020-10-31 | |||
2020-07-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |